The new deadline for the Early Career Investigator LOI will be March 24, 2020 and the Translational Research LOI will be March 25, 2020.
Guest blogger and METAvivor President, Michael Kovarik, talks about his experience as a man living with Metastatic Breast Cancer and how honored and proud he is to be a part of METAvivor.
METAvivor Research and Support announces a new slate of officers for 2020 and new Board Members.
The application portal opens February 18, 2020.
The goal of METAvivor’s Research Award is to provide a supporting foundation for basic, translational, and clinical research designed to address critical problems or barriers to progress in the field of metastatic breast cancer. These awards can be also be discovery based as well for advanced research projects with more well-established/validated models, molecules, pathways, biomarkers, treatments, etc.
The application portal opens February 18, 2020
The Early Career Investigator Award is meant to support novel, high-quality research in metastatic breast cancer performed by the most promising up-and-coming investigators
